Delineate is an AI-driven research operations and analytics platform that converts unstructured scientific and clinical evidence into structured, analysis-ready datasets, automates literature search and triage, and extracts quantitative values from text, tables, and figures for model-informed drug development workflows.
Published Oct 6, 2026
| Starting price | Not public (appears enterprise/services-led) | Pricing shown as available by term; specific enterprise pricing typically provided on request | Custom pricing for commercial customers; free academic tier available |
| Most appropriate for | Biopharma teams needing structured datasets extracted from literature and figures for MIDD/MBMA/trial design | Literature search and evidence workflows using a well-established biomedical database | Central R&D data platform (ELN/registry/workflows); not primarily an evidence-extraction product |
| Key strengths | Vendor emphasis on extracting data from plots/figures and automated triage for evidence aggregation | Mature indexing and search; widely used in systematic review workflows | Deep lab workflow digitization and data unification; broad adoption in biotech |
| Key weaknesses | Limited public security/compliance documentation; limited independent reviews; pricing unclear | Not designed for automated extraction from figures; still requires manual effort for extraction | Not designed specifically for clinical evidence extraction; may require integration to serve that use case |
—
Sources: Accelerator/company public pages; professional social profile information; official vendor product and pricing pages.